Cruise Ship Health Scares Raise Industry Risk Concerns Amid Recent Outbreaks Trumps Iran Escalation Berkshires Airline Move and Lululemons Activist Fight Lead Mondays Market Focus Adani Group Reaches 18 Million Settlement in US Civil Fraud Case MINISO MNSO Reports Strong Q4 2025 Revenue NA EPS Beats AEX Index Dips 021 as Netherlands Stocks Close Lower OpenAI Gains Early Advantage in AI IPO Race as Confidential Filing Reports Emerge Donald Trump Sr to Miss Sons Wedding ExSpouse Vanessa Trump Discloses Breast Cancer Diagnosis JPMorgan Chase Declares Quarterly Dividend of 150 per Share Vestas Wind Systems Stock Slides on Margin Guidance Concerns Nvidias 2400 Dividend Hike Still Highlights Growth Over Income UAVS Q3 2023 Earnings EPS Beats Estimate Amid Revenue Absence Stock Surges 505 Rollins Inc ROL Q1 2026 Earnings Slight EPS Beat Amid Steady Pest Control Demand Banner Corporation BANR Q1 2026 Earnings Earnings Beat Expectations on Strong Operating Performance Hubbell Q1 2026 Earnings Slight EPS Miss Fails to Dampen Investor Sentiment as Core Segments Hold Steady CACI Q1 2026 Earnings EPS Beats Estimates Stock Gains 23 American Financial Group Inc AFG Q1 2026 Earnings EPS Misses Estimates Amid Modest Stock Decline Federal Realty Trust Edges Higher Amid Steady REIT Sector Senstar Technologies SNT Slips 127 as Stock Tests Key Support Near 259 Cadrenal Therapeutics CVKD Slides 52 as Support Level Comes into Focus Primech Holdings PMEC Declines Over 8 as Selling Pressure Mounts K Wave Media KWM Edges Higher Testing Key Resistance at 028 Alvotech Warrant ALWOW Hovers at 018 Amidst Minimal Price Movement Republic Bancorp RBCAA Holds Near Support Amid Modest Pullback GreenTree Hospitality GHG Retreats Near Support Trading at 112 MBINL Preferred Shares Edge Higher as Income Investors Seek Stability Diversified Healthcare Trust 5625 Senior Notes 2042 DHCNI Hold Steady Near 1838 Following Modest Uptick CoalFired Ambitions How China Leverages Coal to Dominate Global Energy Markets WDH Q3 2025 Earnings EPS Beats Estimates by 649 Amid Steep Stock Decline Dyne Therapeutics DYN Surges 587 as Biotech Momentum Builds